Interferon

Therapeutic effectiveness can be predicted early in chronic hepatitis C

Published in Hepatitis Weekly, March 4th, 2002

by Sonia Nichols, senior medical writer - In as little as 2 weeks, doctors can predict whether or not an individual with chronic hepatitis C will respond to interferon therapy, medical researchers in Japan report.

"We conducted a prospective, controlled, multicenter trial to assess if earlier changes of serum hepatitis C virus (HCV) RNA levels were predictable for long-term effect, and if a short-term therapy was effective in such patients," S. Kakumu and coauthors said in the February 2002 issue of Hepatology Research.

Their findings suggested that testing for viral markers early in the treatment process could provide important information...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-03-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry